pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 12·2 min read
save

STAT+: Hims takes a $33 million hit from GLP-1 ‘pivot’

In this edition of STAT Health Tech: Hims earnings, Omada's PBM strategy, and the uphill battle faced by new sepsis algorithms.

May 12, 2026·read at STAT ↗

STAT PlusNewsletterHealth Tech Newsletter Hims takes a $33 million hit from GLP-1 ‘pivot’ You’re reading the web edition of STAT’s Health Tech newsletter Manage alerts for this article Email this article Share this article By Mario AguilarMay 12, 2026 Health Tech Correspondent Mario Aguilar[email protected]Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter.

You can reach Mario on Signal at mariojoze.13. You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Good morning health tech readers!Advertisement Today, my colleagues Isabella Cueto and Lev Facher are launching the Deadliest Drug, a series on the often ignored public health crisis around alcohol, which kills nearly 500 Americans every day. Start with the lead story spelling out the problem and make sure to check out the whole package exploring its many dimensions. STAT+ Exclusive Story Already have an account?

Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%!

Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In health tech, Health Tech Newsletter, STAT+ Submit a correction requestReprints Mario Aguilar Health Tech Correspondent Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

STAT+ Newsletter A hitchhiker's guide to the health care AI galaxy Recommended Health Tech Newsletter May 7, 2026 STAT Plus: OpenAI’s health policy wishlist, CGM news from Dexcom, and more Health Tech Newsletter May 5, 2026 STAT Plus: Did AI really beat doctors at diagnosis? Advertisement Health Tech Newsletter April 30, 2026 STAT Plus: Hinge has a new FDA-cleared migraine device Health Tech Newsletter April 28, 2026 STAT Plus: Google’s clinical director on AI challenges Health Tech Newsletter April 23, 2026 STAT Plus: AMA calls for regulatory crackdown on chatbots, wellness AI Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
484 words · retrieved May 12
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
GLP-1 receptor2

related stories

  • May 28CVS obesity drug deal puts Lilly on equal footing with NovoBioPharma Dive
  • May 19STAT+: Dexcom CEO hints at future uses for CGMSTAT
  • May 18Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drugBioPharma Dive
  • May 18STAT+: Pharmalittle: We’re reading about U.S. biotech’s China problem, a Regeneron flop, and much moreSTAT
  • May 15FDA hold puts Aardvark Prader-Willi drug in limboBioPharma Dive